Top Ad
No Image Available

DTP-HepB-Hib (Pentavalent) Vaccine

Form: Injectable suspension (IM injection)

Strength: 0.5 mL dose

Reference Brands: Pediarix(US)

Category: Vaccines

DTP-HepB-Hib pentavalent vaccines are approved in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves rigorous clinical evaluations, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and extensive audits, with documentation including safety profiles, clinical trial data, and manufacturing details. For detailed licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees timely access to safe, effective vaccines vital for global immunization efforts, reducing childhood disease burden worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Inactivated Vaccines

Strength: Dose and concentration depend on formulations

Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution

Reference Brands: Sinovac Coronavac. Covaxin(EU)

View Details Get Enquiry
Viral Vector Vaccines

Strength: 0.5 mL

Form: Intramuscular injectable suspension (IM)

Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)

View Details Get Enquiry
mRNA-based Vaccines

Strength: 30 µg and 100 µg

Form: Injectable suspension

Reference Brands: Comirnaty, Spikevax(US)

View Details Get Enquiry
Meningococcal Vaccine

Strength: 0.5 mL

Form: Vial or pre-filled syringe (injectable), Conjugate vaccines

Reference Brands: Menactra, Menveo(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.